Executive Solution Overview
– ## 6table.docx **## 6table.docx** | | | | | | | — | — | — | — | — | | Drug Name | Indication<br>Neurotransmitter(s) Affected <br>Target Symptoms | Half-life (T1/2), Metabolism (CYP 450 enzyme) | Notable Side Effects (link to NT or affected brain circuit) | Initial Dosing Considerations<br>Specific lifespan considerations (age, pregnancy…
Instant Solution Download
.99Immediate access to the full model answer, formatted citations, and rubric breakdown.
Need a Fresh Custom Paper?
Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →Assignment Prompt & Instructions
– ## 6table.docx **## 6table.docx** | | | | | | | — | — | — | — | — | | Drug Name | Indication<br>Neurotransmitter(s) Affected <br>Target Symptoms | Half-life (T1/2), Metabolism (CYP 450 enzyme) | Notable Side Effects (link to NT or affected brain circuit) | Initial Dosing Considerations<br>Specific lifespan considerations (age, pregnancy, breastfeeding) | | **Buprenorphine** (Subutex) | | | | | | **Buprenorphine/Naloxone** (Suboxone, Zubsolv, Bunavail) | | | | | | **Methadone** (Dolophine, Methadose) | | | | | | **Naltrexone** (Revia, Vivitrol) | | | | | | **Acamprosate** (Campral) | | | | | | **Disulfiram** (Antabuse) | | | | | Instructions below: 1. For each medication listed, complete the following: a. Provide indication, target symptoms, and affected neurotransmitters. b. Include half-life and CYP 450 enzyme information. c. List notable side effects and link notable side effects to the associated pathway or neurotransmitter. d. List Initial Dosing Considerations and specific lifespan considerations (age, pregnancy, breastfeeding). e. Organization font is consistent throughout table, grammar, spelling, and/or punctuation are accurate. f. **## 6table.docx** | | | | | | | — | — | — | — | — | | Drug Name | Indication<br>Neurotransmitter(s) Affected <br>Target Symptoms | Half-life (T1/2), Metabolism (CYP 450 enzyme) | Notable Side Effects (link to NT or affected brain circuit) | Initial Dosing Considerations<br>Specific lifespan considerations (age, pregnancy, breastfeeding) | | **Buprenorphine** (Subutex) | | | | | | **Buprenorphine/Naloxone** (Suboxone, Zubsolv, Bunavail) | | | | | | **Methadone** (Dolophine, Methadose) | | | | | | **Naltrexone** (Revia, Vivitrol) | | | | | | **Acamprosate** (Campral) | | | | | | **Disulfiram** (Antabuse) | | | | | Instructions below: 1. For each medication listed, complete the following: a. Provide indication, target symptoms, and affected neurotransmitters. b. Include half-life and CYP 450 enzyme information. c. List notable side effects and link notable side effects to the associated pathway or neurotransmitter. d. List Initial Dosing Considerations and specific lifespan considerations (age, pregnancy, breastfeeding). e. Organization font is consistent throughout table, grammar, spelling, and/or punctuation are accurate. f.
